← Back to Patent Explorer
US4816463A Expired / Lapsed US ⏱️ 0.0 years remaining

Substituted diimidazo [1,5-a: 4',5'-d]pyridines having antihypertensive activity

Assignee: Warner Lambert Co LLC
•
Filing: 1987-04-07
•
Granted: 1989-03-28
•
Expires: 2007-04-07
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract This invention relates to novel substituted derivatives of diimidazo[1,5-a:4',5'-d]pyridines and analogs thereof, which are useful for the treatment of hypertension, as well as, novel pharmaceutical compositions, methods of use, and as intermediates for preparing novel substituted derivatives of 4,5,6,7-tetrahydro-1_H-imidazo[4,5-c]pyridine-6-carboxylic acid and analogs thereof having antihypertensive activity.

Inventors

  • 👤 C. John Blankley
  • 👤 John C. Hodges
  • 👤 John S. Kiely
  • 👤 Sylvester R. Klutchko

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-28 10:12
CPC Classifications
C; C07; C07D; C07D471/00; C07D471/02; C07D471/04; C07D471/12; C07D471/14; C07D487/00; C07D487/02; C07D487/04; C07D497/00; C07D497/02; C07D497/04

Claims Analysis

Total Claims: 19
Claim 1
Independent Claim 384 words
A compound having the formula (II) ##STR56## and the nontoxic, pharmaceutically acceptable base or acid addition salts thereof, wherein is a single or double bond; (1) one of R a is present and is (a) hydrogen (b) alkyl of from one to twenty carbons, inclusive, (c) ##STR57## wherein y is zero, one, two, three, four, or five and R' is cycloalkyl of from four to twenty carbons, inclusive in a one, two or three saturated ring system, said ring comprising from four to eight carbons inclusive, each ring unsubstituted or substituted by a straight or branched lower alkyl group, naphthyl, heteroaryl, phenyl unsubstituted or substituted with of from one through five substituents selected from the group consisting of lower alkyl, halo, trifluoroemthyl, hydroxy, lower alkoxy, lower alkyl acyloxy, amino, N-lower monalkylamino, N,N-lower dialkylamino, lower thioalkyl, lower alkylsulfonyl, nitro and ##STR58## wherein R 10 is lower alkyl, phenyl unsubtituted or substituted by lower alkyl, or --NHR 11 wherein R 11 is hydrogen or lower alkyl, and R" is hydrogen, lower alkyl, cycloalkyl of from four to twenty carbons, inclusive in a one, two or three saturated ring system, said ring comprising from four to eight carbons inclusive, each ring unsubstituted or substituted by a straight or branched lower alkyl group, naphthayl, phenyl unsubstituted or substituted with of from one through five substituents selected from the group consisting of alkyl, halo, trifluoromethyl, amino, N-lower monalkylamino, N,N-lower dialkylamino, lower thioalkyl, lower alkylsulfonyl, and nitro; (2) Z is oxygen or sulfur; and (3) R 2 is (a) hydrogen (b) halo, (c) lower alkyl, (d) R'--CH 2 -- x wherein x is one, two, three, four, or five, and R' is independently as defined above, (e) ##STR59## wherein R' is independently as defined above, or (f) R'--CH(OH)-- wherein R' is independently as defined above; (4) R is selected from the group consisting of lower alkyl, heteroaryl, and phenyl or benzyl each unsubstituted or substituted with of from one through five substituents selected from the group consisting of lower alkyl, halo, trifluoromethyl, hyroxy, lower alkoxy, lower alkyl acyloxy, amino, N-lower monoalkylamino, N,N-lower dialkylamino, lower thioalkyl, lower alkylsulfonyl, and nitro; wherein the heteroaryl is 2-, 3-, or 4-pyridyl; 1-, 2-, or 4-imidazolyl; 1-, 2-, 3-, 4-, 5-, 6- or 7-indolyl; 2-, or 3-thienyl, 2-, or 3-furyl; of 1-, 2-, or 3-pyrazolyl.
Claim 2
Dependent Claim 384 words
A compound having the formula (II) ##STR56## and the nontoxic, pharmaceutically acceptable base or acid addition salts thereof, wherein is a single or double bond; (1) one of R a is present and is (a) hydrogen (b) alkyl of from one to twenty carbons, inclusive, (c) ##STR57## wherein y is zero, one, two, three, four, or five and R' is cycloalkyl of from four to twenty carbons, inclusive in a one, two or three saturated ring system, said ring comprising from four to eight carbons inclusive, each ring unsubstituted or substituted by a straight or branched lower alkyl group, naphthyl, heteroaryl, phenyl unsubstituted or substituted with of from one through five substituents selected from the group consisting of lower alkyl, halo, trifluoroemthyl, hydroxy, lower alkoxy, lower alkyl acyloxy, amino, N-lower monalkylamino, N,N-lower dialkylamino, lower thioalkyl, lower alkylsulfonyl, nitro and ##STR58## wherein R 10 is lower alkyl, phenyl unsubtituted or substituted by lower alkyl, or --NHR 11 wherein R 11 is hydrogen or lower alkyl, and R" is hydrogen, lower alkyl, cycloalkyl of from four to twenty carbons, inclusive in a one, two or three saturated ring system, said ring comprising from four to eight carbons inclusive, each ring unsubstituted or substituted by a straight or branched lower alkyl group, naphthayl, phenyl unsubstituted or substituted with of from one through five substituents selected from the group consisting of alkyl, halo, trifluoromethyl, amino, N-lower monalkylamino, N,N-lower dialkylamino, lower thioalkyl, lower alkylsulfonyl, and nitro; (2) Z is oxygen or sulfur; and (3) R 2 is (a) hydrogen (b) halo, (c) lower alkyl, (d) R'--CH 2 -- x wherein x is one, two, three, four, or five, and R' is independently as defined above, (e) ##STR59## wherein R' is independently as defined above, or (f) R'--CH(OH)-- wherein R' is independently as defined above; (4) R is selected from the group consisting of lower alkyl, heteroaryl, and phenyl or benzyl each unsubstituted or substituted with of from one through five substituents selected from the group consisting of lower alkyl, halo, trifluoromethyl, hyroxy, lower alkoxy, lower alkyl acyloxy, amino, N-lower monoalkylamino, N,N-lower dialkylamino, lower thioalkyl, lower alkylsulfonyl, and nitro; wherein the heteroaryl is 2-, 3-, or 4-pyridyl; 1-, 2-, or 4-imidazolyl; 1-, 2-, 3-, 4-, 5-, 6- or 7-indolyl; 2-, or 3-thienyl, 2-, or 3-furyl; of 1-, 2-, or 3-pyrazolyl.
Claim 3
Dependent Claim 34 words
A compound according to claim 1 wherein Z is as defined above and R is branched alkyl of from three to five carbons, inclusive, or phenyl substituted by one, two or three methoxy groups.
Claim 4
Dependent Claim 76 words
A pharmaceutical composition for treating hypertension is mammals comprising an antihypertensive effective amount of the compound of formula (IIa) ##STR60## wherein Z is oxygen or sulfur and R 11 is branched alkyl of from three to five carbons, inclusive, and phenyl substituted with of from one through five substituents comprising lower alkyl, halo, trifluoromethyl, hydroxy, lower alkyl, lower alkyl acyloxy, amino, N-lower monoamino, N,N-lower dialkylamino, lower thioalkyl, lower alkylsulfonyl, or nitro, and a pharmaceutically acceptable carrier.
Claim 5
Dependent Claim 76 words
A pharmaceutical composition for treating hypertension is mammals comprising an antihypertensive effective amount of the compound of formula (IIa) ##STR60## wherein Z is oxygen or sulfur and R 11 is branched alkyl of from three to five carbons, inclusive, and phenyl substituted with of from one through five substituents comprising lower alkyl, halo, trifluoromethyl, hydroxy, lower alkyl, lower alkyl acyloxy, amino, N-lower monoamino, N,N-lower dialkylamino, lower thioalkyl, lower alkylsulfonyl, or nitro, and a pharmaceutically acceptable carrier.
Claim 6
Dependent Claim 27 words
A composition of claim 3 wherein R 11 is branched alkyl of from three to five carbons, inclusive and phenyl substituted by one to three methoxy groups.
Claim 7
Dependent Claim 25 words
A method of treating hypertension in mammals suffering therefrom comprising administering to said mammals an antihypertensive effective amount of the composition according to claim 3.
Claim 8
Dependent Claim 13 words
A chemical compound according to claim 2 in which the compound is 1,4,6,7,8a,9-hexahydro-7-phenyl-1-(phenylmethyl)-6-thioxo-8H-diimidazo[1,5-a:4',5'-d]pyridine-8-one.
Claim 9
Dependent Claim 14 words
A chemical compound according to claim 2 in which the compound is 6,7,8a,9-tetrahydro-1-[(4-methoxy-3-methylphenyl)-methyl]-7-(4-methoxyphenyyl)-6-thioxo-1H-diimidazo[1,5-a:4',5'-d]pyridine-8;l (4H)-one.
Claim 10
Dependent Claim 13 words
A chemical compound according to claim 2 in which the compound if 6,7,8a,9-tetrahydro-7-(4-methoxyphenyl)-1-(phenylmethyl)-6-thioxo-1H-diimidazo[1,5-a:4',5'-d]pyridine-8(4H)-one.
Claim 11
Dependent Claim 13 words
A chemical compound according to claim 2 in which the compound is (S)-8a,9-dihydro-3-methyl-7-(1-methylethyl)-3H-diimidazo[1,5-a:4',5'-d]pyridine-6,8(4H,7H)-dione.
Claim 12
Dependent Claim 13 words
A chemical compound according to claim 2 in which the compound is 8a,9-dihydro-7-(1-methylethyl)-1-(phenylmethyl)-1H-diimidazo[1,5-a:4',5'-d]pyridine-6,8(4H,7H)-dione.
Claim 13
Dependent Claim 14 words
A chemical compound according to claim 2 in which the compound if 8a,9-dihydro-7-(1-methylethyl)-1-(phenylmethyl)-1H-diimidazo[1,5-a:4',5'-d]pyridine-6,8(4H,7H)-dione hydrobromide.
Claim 14
Dependent Claim 13 words
A chemical compound according to claim 2 in which the compound is 3H-diimidazo[1,5-a:4',5'-d]pyridine-6,8(4H,7H)-dione,8a,9-dihydro-3-methyl-7-phenyl-.
Claim 15
Dependent Claim 13 words
A chemical compound according to claim 2 in which the compound is 1H-diimidazo[1,5-a:4',5'-d]pyridine-6,8(4H,7H)-dione,8a,9-dihydro-1-methyl-7-(1-methylethyl)-.
Claim 16
Dependent Claim 13 words
A chemical compound according to claim 2 in which the compound is 1H-diimidazo[1,5-a:4',5'-d]pyridine-6,8(4H,7H)-dione,8a,9-dihydro-7-(4-methoxyphenyl)-1-(phenylmethyl)-.
Claim 17
Dependent Claim 13 words
A chemical compound according to claim 2 in which the compound is 1H-diimidazo[1,5-a:4',5'-d]pyridine-6,8(4H,7H)-dione,8a,9-dihydro-7-(4-methoxyphenyl)-1-(phenylmethyl)-,monohydrochloride.
Claim 18
Dependent Claim 14 words
A chemical compound according to claim 2 in which the compound is 1H-diimidazo[1,5-a:4',5'-d]pyridine-6,8(4H,7H)-dione,8a,9-dihydro-1-[(4-methoxy-3-methylphenyl)methyl]-7-(4-methoxyphenyl)-, (S)-.
Claim 19
Dependent Claim 13 words
A chemical compound according to claim 2 in which the compound is 1H-diimidazo[1,5-a:4',5'd]pryidine-6,8(4H,7H)-dione,8a,9-dihydro-1-[(4-methoxy-3-methylphenyl)methyl]-7-(4-methoxyphenyl)-,monohydrochloride,(S)-.

References Cited (Backward Citations)

US4141899A Cited
JPS5995286A Cited
BE902611A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1992-03-27 1992-09-26 1993-03-28 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1996-03-27 1996-09-26 1997-03-28 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2000-03-27 2000-09-26 2001-03-28 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag